Efficient pregnancy studies that satisfy your regulatory requirements

When it comes to pregnancy
studies, this is what we do best

Agile Global
Infrastructure
Superior
Study Design
Secure Data
Management
Tested
Engagement Tactics

Agile Global
Infrastructure

  • Capable of rapid study deployment in any part of the world
  • Pregistry’s global teams can quickly assemble technical infrastructure and use native technical tools to access data quickly and safely

Superior
Study Design

  • Observational, prospective, cohort studies
  • All study documents, including study protocol, Informed Consent Form, questionnaire modules, and Statistical Analysis Plan are reviewed and approved by a world-class external Scientific Advisory Committee

Secure Data
Management

  • Information collected directly from participants in accordance to GDPR
  • Secure intranet communication
  • Customizable participant modules
  • Active management of safety signals in accordance with GVP Module IX

Tested
Engagement Tactics

  • Highly skilled concierge team
  • Real-time communication with study participants
  • Study awareness campaigns via social media and online parenting communities
  • Personalized study newsletters and feedback

Ongoing Studies

PIPER

The Pregistry International Pregnancy Exposure Registry (PIPER) is a study of pregnant people to understand the safety profile of medications and vaccines when used during pregnancy. Online surveys are used to collect information about the pregnancy and the baby up to 12 months after birth. Participants enroll during pregnancy and must be 18 years or older.

Find out more
8172 Participants

C-VIPER

The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER) is a research study that focuses on learning about COVID-19 vaccines during pregnancy. Participants are 18 years of age or older, pregnant at the time of enrolment, and have had a COVID-19 vaccine during this pregnancy or right before it.

Find out more
368 Participants

COVID-PR

With more than 360 participants and counting, the COVID-19 International Drug Pregnancy Registry (COVID-PR) focuses on monoclonal antibodies and antivirals used to treat COVID-19 during pregnancy. Participants are age 18 or over, currently pregnant or gave birth just before enrolling, and were treated for COVID-19 during pregnancy.

Find out more

Completed Studies

17318 Participants

International Registry of Coronavirus Exposure in Pregnancy (IRCEP)

The IRCEP studied pregnant and recently pregnant people who were or may have been infected with SARS-CoV-2, the virus that causes COVID-19. Read our scholarly articles about this study here.

Pharmaceutical partners: Johnson & Johnson and Regeneron.
Academic partner: Department of Epidemiology, Harvard TH Chan School of Public Health.

6894 Participants

Mental Health and Wellbeing of Pregnant and Recently Pregnant People During the COVID-19 Pandemic.

We studied an international sample of 6894 pregnant people from 64 countries to learn about how the COVID-19 pandemic impacted their mental health and wellbeing. Read our scholarly articles about this study here.

Academic partner: Department of Psychiatry, Massachusetts General Hospital

17871 Participants

Vaccine Hesitancy Among Pregnant Women and Mothers of School-Aged Children

We asked 17871 study participants from 16 countries if they would get a COVID-19 vaccine for themselves while pregnant or for their children. Read our scholarly articles about this study here.

Academic partner: Department of Global Health and Population, Harvard TH Chan School of Public Health

Contact us today to schedule your consultation